Skip to main content
. 2017 Nov 9;24(8):1754–1757. doi: 10.1016/j.sjbs.2017.11.006

Table 2.

Relationship between the expression of Tim-3 and the clinicopathological features of pancreatic cancer.

Parameter Group No. Tim-3
χ2 P value
(+) (−)
Gender Male 30 21 9 0.149 .700
Female 20 15 5



Age ≥50 40 30 10 0.304 .581
<50 10 6 4



History of smoking Yes 34 28 6 4.158 .041
No 16 8 8



Fasting blood glucose (mmol/L) <6.1 38 31 7 5.363 .021
≥6.1 12 5 7



Tumor size (cm) >2 23 21 2 7.873 .005
≤2 27 15 12



Tumor location Head of pancreas 35 27 8 0.304 .581
Non-head of pancreas 15 9 6



TNM stage III-IV 12 5 9 10.322 .001
I-II 38 31 5



Pathological type Ductal adenocarcinoma other 46 35 11 2.567 .109
4 1 3



Degree of tumor differentiation Moderately and poorly differentiated 45 34 11 1.334 .248
Well differentiated 5 2 3



CA199 (μ/ml) >37 40 33 7 8.488 .004
<37 10 3 7